BACKGROUND: The goal of this study was to develop and validate a dynamic risk model to predict daily changes in acute brain dysfunction (ie, delirium and coma), discharge, and mortality in ICU patients.
Acute brain dysfunction (ie, delirium and coma) during critical illness is a form of organ dysfunction that has a substantial impact on patients' clinical management. The majority of ICU patients experience acute brain dysfunction at some point during their ICU stay. [1] [2] [3] [4] ICU delirium is an independent risk factor for death, [5] [6] [7] [8] cognitive dysfunction, 4,9,10 longer lengths of stay, 11, 12 and higher costs. 13, 14 Despite the clinical significance of acute brain dysfunction and its recognition as an indicator of quality and safety, 15 there are few risk prediction tools that adequately predict the number of patients likely to experience acute brain dysfunction. To date, only two ICU delirium prediction models have been published: the Early Prediction of Delirium in ICU Patients (E-PRE-DELIRIC) 16 model and the Prediction of Delirium in ICU Patients (PRE-DELIRIC) model. 17, 18 These models consist of up to 10 clinical factors present up to the first 24 ICU hours. They are excellent models that predict the first-time incidence of ICU delirium. Although important, these models are limited to patients without delirium at admission, do not factor in dynamic daily risk factors, and cannot predict recurrent or ongoing delirium.
One may complement the PRE-DELIRIC models with a tool to assess the risk for delirium each day while in the ICU. For example, when a patient arrives at the ICU, his or her brain function is measured to be in one of three mutually exclusive states: normal, delirious, or comatose. Each subsequent day, patients may continue in their current state, transition to a new brain function state, be discharged from the ICU, or die. Each of these outcomes might be predicted by using a transitional modeling approach, which we call the acute brain dysfunctionprediction model (ABD-pm). Table 1 summarizes comparisons between the PRE-DELIRIC and ABD-pm modeling approaches.
The goal of the present study was to develop a tool to accurately predict the number of patients in any given brain function state the next day, discharged, or died.
Patients and Methods

Study Design and Population
We included patients enrolled in the Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors (BRAIN-ICU). 4, 19 This study enrolled a cohort of critically ill patients at two tertiary care medical centers (Vanderbilt University Medical Center and St. Thomas Hospital, Nashville, Tennessee). 4, 20 The study protocol and the eligibility criteria have been published 4 and are presented in e-Appendix 1. Adults ($ 18 years old) admitted to medical or surgical ICUs were included who received treatment for respiratory failure or shock. 21, 22 We excluded those with recent ICU exposure and who could not perform in-person follow-up. The institutional review board at Vanderbilt University Medical Center approved the study.
Candidate Predictors
Candidate factors at ICU admission included the following: age, ICU type, use of medications to treat Alzheimer's disease, Acute Physiology and Chronic Health Evaluation II (APACHE II) acute physiology score, 23 26 and ICU day number (daily updated length of stay, modeled by using a secondorder polynomial). 27, 28 Additional daily factors included administration of benzodiazepines, 24, 29 opiates, 29 propofol, 17, 24 antipsychotic agents, 29 and statins. 30 Detailed factor definitions, rationale, and missing data approaches are available in e-Appendix 1. Table 1 ). Arousal level and delirium were assessed in the ICU at least twice per day by trained research nurse coordinators in all patients for up to 30 days. ICU discharge and death were final states from which no further transitions were possible. 35 With five possible outcomes, there were 15 possible transitions (Fig 1) .
Statistical Analysis
A transition model of in-hospital outcomes is important when considering outcomes that change from day to day. 36 The ABD-pm dynamic state transition model was implemented by using multinomial logistic regression to estimate the next-day probability of acute brain dysfunction, ICU discharge, and ICU death. 37 The model estimated the probability of transition to one of five function states (normal, delirium, comatose, discharged from ICU, or deceased), adjusting for current brain function state (normal, delirious, or comatose), baseline risk factors, and time-varying clinical risk factors acquired during the ICU stay. 38, 39 Each transition day was treated as conditionally independent (ie, conditional on the previous mental state and other daily and baseline patient factors).
The final model was selected sequentially. The base model included the current brain function status only. This step was followed by addition of enrollment demographic/comorbidity predictors, severity of illness factors, daily medications, and ICU length of stay. At each stage, likelihood ratio testing was conducted to assess the independent prognostic significance for each factor group. Also, we included interactions of study day with baseline APACHE II score and baseline mechanical ventilation to model the differential impact of these baseline covariates on the first day of ICU stay vs later days. Internal validation and interval estimation of model fit statistics were performed by using a bootstrap method with 5,000 resamples. 40 Discrimination was assessed by calculating sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for each transition. Accuracy (the proportion of patients with correct classifications) was additionally assessed. Unlike traditional prediction models of binary outcomes (eg, mortality) that assess discrimination by using receiver-operating characteristic curves, there is no agreed-upon method for multiclass outcomes. 41 Because clinicians often want to understand how a test predicts a specific outcome, the discussion was focused on PPV and NPV. To provide greater clinical context, we additionally calculated the predicted outcome states for the second ICU day in a randomly selected group of 100 patients admitted to the ICU, 26%, 33%, and 41% of whom were normal, delirious, and comatose, respectively, upon admission.
These 100 patients had the following characteristics: mean age, 60.6 years; mean APACHE II score, 17.3; severe sepsis, 62%; mechanically ventilated, 87%; and had received benzodiazepines, 34%.
To assess calibration, we used the model to estimate transitional probabilities for each patient transition. Model-based estimates were compared with empirical estimates by using a scatter plot smoother (ie, a calibration plot). A well-calibrated model has good agreement between the model-based and empirical estimates of transition probabilities. Calibration plots were constructed for each of the five outcome states, regardless of the starting brain function state. We refer to this approach as "population-level" calibration, as the predicted outcomes represent sums of the individual transition-level probabilities. For example, the predicted number of delirious patients would be the total number of patients predicted to transition from coma, delirium, or normal to delirium over the next day. Population-level calibration was assessed across all study days as well as for the first ICU day, as the first ICU day is a critical day for ICU management. Individual transition-level calibration plots were also constructed for each of the 15 possible transitions.
The statistical software package R, version 2.15.2, and the R package 
Results
A total of 826 patients were enrolled in the BRAIN ICU study. Five patients withdrew consent and their collected data; 11 patients died or withdrew within 24 h of ICU admission. Thus, 810 patients were included (e -Fig 1) , with a median (interquartile range) age of 61 years (51-71 years) and high severity of illness (APACHE II score: 25 [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] ) (Table 2) , 23, 26, 42, 43 with 6,711 day-to-day transitions. Delirium affected 606 (75%) patients at some time during their ICU stay. Patients were normal, delirious, comatose, discharged, or died for 29%, 30%, 29%, 10%, and 2% of ICU days, respectively (Table 3) . Additional daily covariates are given in Table 3 . More desirable outcomes are at the top of the figure, whereas less desirable outcomes are found at the bottom of the figure. Note each state is mutually exclusive and that ICU discharge and death are considered final states, from which no additional transitions can take place.
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Final Model Predictors
Of the 15 potential risk factors considered for predicting the various transition states, only daily statin administration was excluded, given the low likelihood ratio statistic (18.3; P ¼ . 25) found in reduced models without statins. All other variables remained in the final model, consisting of 14 individual risk factors and two prespecified interaction terms.
Model Discrimination
Overall, specificity and NPV were greater than sensitivity and PPV for all transitional outcome states. The bootstrap-validated sensitivity and specificity for delirious predictions were 0.597 (95% CI, 0.576-0.618) and 0.792 (95% CI, 0.778-0.803), with a PPV and NPV of 0.548 (95% CI, 0.539-0.556) and 0.823 (95% CI, 0.817-0.828), respectively. Compared with the overall daily prevalence of each brain function outcome (ie, normal, 0.29 of ICU days; delirious, 0.30 of ICU days; and comatose, 0.29 of ICU days), the PPVs (ie, posttest probability) of each outcome measure were substantially greater. Overall accuracy was highest for the deceased state (0.981 [95% CI, 0.979-0.981]), which is largely due to the rarity of mortality in this population (Table 4) . 23, 26 Population-level Calibration Across the population and over the entire study period, model predictions of the population's clinical conditions (remain in the ICU, discharge from the ICU, or death) closely approximated actual observations (Fig 2) with slight deviations beyond 7 days. Population-level calibration for each outcome state was outstanding for normal, delirium, coma, and ICU discharge but not for mortality (Fig 3) . Population-level predictions of death, however, were greater than observed at higher predicted Scores on the Short IQCODE range from 1 to 5, with a score of 3 indicating no change in cognition over the past 10 years, a score < 3 indicating improvement, and a score > 3 indicating decline in cognition, compared with 10 years before. A score $ 3.3 indicates an increased probability of cognitive impairment, and a score $ 3.6 indicates preexisting cognitive impairment. Scores on the SOFA range from 0 to 24 (from 0 to 4 for each of six organ systems), with higher scores indicating more severe organ dysfunction. A modified SOFA score was used in the regression models, which excluded the Glasgow Coma Scale components (hence ranging from 0-20) because coma was included separately in our models. probabilities. When assessing the first day only, population-level prediction continued to be excellent for brain function outcomes (e -Fig 2) , whereas predictions for discharge on the first day were greater than observed.
Transition-level Calibration or Individual-level Calibration
Calibration was additionally examined at the "transition-level" or "individual-level" (e-Figs 3-5). For specific transitions, the model was well calibrated for transitions from normal to delirium, delirium to delirium, and coma to delirium. The model, however, underpredicted transitions of delirium to deceased and comatose to discharge, as indicated by the lower confidence bound crossing the slope of 1 that would indicate perfect calibration. Overpredictions were most apparent for the transitions of normal to coma, normal to deceased, and delirious to normal, as indicated by the upper confidence bound crossing the slope of 1. Deviations were most notable at the high range of predictions in which the 95% confidence bands were the widest and were related to the rare outcome frequency.
One can see the daily transition probabilities based upon the previous day brain function state in e- Table 2 .
Discussion
We have developed an ABD-pm that predicts daily changes in brain function status while in the ICU and Table 2 Figure 2 -Clinical trajectory of patient population by study day and matching model prediction. The figure illustrates the proportions of the initial patient cohort that were deceased, discharged, or remained in the ICU on each study day. In each case, the solid lines represent the observed proportion, whereas individual symbols represent the modelpredicted proportions. Each prediction was made using all available information up to that point. This model, as with the model in Figure 3 , shows outstanding calibration when predicting the total number of patients expected to be in any given state across predicted risk.
Fraction of Patients
chestjournal.org accounts for competing outcomes of discharge and death. The ABD-pm may be particularly useful for predicting a distribution of cognitive states in the ICU, ICU discharge, and mortality across the entire ICU population. Furthermore, the ABD-pm model may aid inpatient counseling regarding the next-day probability of being alive (NPV for mortality: 0.981) or of being in the impaired cognitive states of either delirium or coma (NPV for normal cognitive state: 0.874) or of remaining in the ICU (NPV for discharge: 0.905).
Although complementary to the PRE-DELIRIC 17,18 ICU delirium prediction models, the ABD-pm differs in important ways. First, the ABD-pm not only predicts day-to-day changes in delirium but additionally predicts transitions to competing brain function states (coma and normal), discharge, and death. Coma, for example, not only is predictive of delirium but entails its own prognostic significance. 6, 44 If observed delirium rates are increased, it is potentially important to understand if the increases were predicted with increasing transitions from coma (which signals improving brain function), or rather from increasing predicted transitions from normal (which signals worsening brain function). A second difference of the daily ABD-pm is its dynamic nature to predict next-day acute brain dysfunction, discharge, or death on any given ICU day. Importantly, acute brain dysfunction and its risk factors fluctuate from day to day, and the ABD-pm can incorporate these time covariates to provide updated information each ICU day.
The unique model characteristics of the daily ABD-pm allows predictions for patient groups. For example, patients already admitted with delirium (prevalent delirium) are excluded in an ICU delirium incidence model (eg, PRE-DELIRIC) but are included in the daily ABD-pm. This population is important, especially given the known association of delirium duration with longterm cognitive dysfunction 4,9 and mortality. 5, 6 Given a population's characteristics, one can predict the number of patients likely to be alive in a given cognitive state, discharged, or deceased, on any given day. For example, using our prediction model, we calculated the predicted outcome states for the second ICU day in a randomly selected group of 100 patients admitted to the ICU, 26%, 33%, and 41% of whom were normal, delirious, and comatose, respectively, upon admission and had the following characteristics: mean age, 60.6 years; mean APACHE II score, 17.3; severe sepsis, 62%; mechanically ventilated, 87%; and had received benzodiazepines, 34%. This group would be predicted to have the following outcomes: 19 normal, 25 delirious, 41 comatose, 13 ICU discharges, and 2 ICU deaths on the next day. This information can have system-wide implications in resource planning. For example, consider this population in an ICU or across a hospital's critical care population. One would know that the population of comatose patients will likely require mechanical ventilation and not be able to participate in ambulatory activities, whereas patients expected to be discharged will require additional ward staff and beds. Because of the high costs of ICUs, precise quality assurance and utilization management strategies are essential.
Additional system-wide implications for the ABD-pm model include the ability to apply predictions for Figure 2 , shows outstanding calibration when predicting the total number of patients expected to be in normal, delirious, comatose, and discharged states across predicted risk. Calibration remained excellent for mortality; however, this model appears to overpredict mortality at higher predicted mortality probabilities. Once again, the wide confidence levels at these predicted probabilities are indicative of smaller sample sizes.
performance measurement. For example, predicted probabilities could be used for benchmarking, by comparing the number of observed to expected outcomes states, for a specific ICU day, or across all ICU days. A population with more delirium and coma than predicted may prompt an investigation into populationlevel treatment practices that are having a negative impact on acute brain dysfunction outcomes. Alternatively, if there is less delirium and coma than predicted, one may learn of new processes leading to reductions in acute brain dysfunction. Each may be important tools in evaluating ICU quality and safety.
Clinicians often wish to know how well a test predicts an outcome. PPV is the probability that a positive test result predicts a specified outcome, whereas NPV is the probability that a negative test result predicts the absence of that same outcome. At the transition or individual level, the daily ABD-pm exhibited moderate PPV and outstanding NPV. It is not surprising that both PPV would be low and that calibration would be poor for rare transitions (eg, normal to coma, normal to deceased, comatose to discharge) that occur in < 2% of patient days. This does not mean that the model does not add information. For example, whereas the pretest probability of mortality (the overall prevalence of outcomes) is 0.02, the PPV is 0.29. Therefore, the model substantially increases the predicted probability of mortality, although not to the level that an individual clinician would make a specific clinical decision based on that information. Future studies that include a larger sample size may provide a greater number of such transition states and reduce the uncertainty in these predictions; however, due to lower prevalence, the PPV may still be below an actionable level. In contrast, the high NPV for outcome states may be more clinically useful for the ABD-pm model. For example, a high NPV (0.875) for a normal state may guide a clinician's counseling of a caregiver regarding expectations for the patient's ongoing neurologic dysfunction. Likewise, a high NPV for ICU discharge (0.905) may be helpful for a clinician or ICU manager to understand the likely need for continued ICU care for a patient.
In addition to informing prognosis and care needs for an individual patient, transition-level predictions may help risk-stratify patients to prioritize care. For example, a provider (eg, a physical therapist) may be able to identify those patients most likely to experience delirium the following day (ie, those having the highest predicted probability for delirium). Although the PPV may not allow for precise predictions of delirium, the physical therapist (a limited resource) will still be able to prioritize early mobility interventions (a potent delirium prevention intervention) 45 to those patients with the highest predicted probabilities. Another example would be for targeting enrollment into a clinical trial to include the patients at the highest risk of transitioning into delirium from a specific state, thus enriching a treatment population for those at the highest risk.
Future research is needed to externally validate our model. Validation could allow development of an ICU report card that summarizes adherence to evidencebased preventive measures in the ICU and could be used to identify areas needing improvement and to drive quality improvement efforts. Efforts to improve quality need to be measured to show whether these practices lead to effective improvement in ICU care. Validation of this model could help to identify and compare best practices within an organization, to compare current practice over time and also between organizations to judge performance and identify improvements that have proven to be successful in other organizations.
There are important limitations to consider in the daily ABD-pm. First, this model was developed and internally validated; thus, the model will require external validation. Another limitation is that the outcomes were measured only twice daily. Delirium and coma may change more frequently, although the present data would be unlikely to be biased in one direction. The study model was also limited by only relying on data prospectively available in our electronic medical record and in a coded format. Although some other factors are predictive, we believed it was critical to use predictors likely to be found in electronic medical records to simplify future implementation. Some predictors were less prevalent during the time of study (eg, dexmedetomidine) that may be predictive and warrant investigation in future models.
Conclusions
We showed that the daily ABD-pm can predict the dynamic course of acute brain dysfunction for an ICU population. In addition, the model predicts the risk of death and discharge, both of which are competing risks for acute brain dysfunction. The daily ABD-pm can be applied regardless of whether patients are admitted to the ICU with delirium, which will serve as an advantage when testing whether this instrument is valid as a surveillance tool for acute brain dysfunction outcomes across ICU populations.
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